Symbiotica Speciality Ingredients Sdn Bhd, a company focused on complex steroidal Active Pharmaceutical Ingredients (APIs), has secured a $100K grant. The funding marks a significant boost for the firm, which specializes in delivering high-quality APIs essential for global health and well-being.
As a leading player in its niche, Symbiotica is driven by a vision to remain at the forefront of pharmaceutical ingredient innovation. This capital will support its ongoing work in developing and supplying critical components to the healthcare industry.
%20Sdn%20Bhd.png&w=3840&q=75)
.png&w=3840&q=75)
